Primary Packaging Overfilling With Vacuum-Assisted Stoppering

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Primary packaging components, such as syringes, often have nominal volumes that are less than the desired volume of formulated drug substance, leading to issues with viscosity, compatibility with delivery devices, increased costs, and compromised sterility due to air exposure and agitation.

Innovation Solution

A method of overfilling primary packaging components with a formulated drug substance beyond their nominal volume using vacuum-assisted stoppering, ensuring the stopper is positioned correctly to maintain integrity and sterility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If the nominal volume of the primary packaging component is increased to match the desired dosage volume, then the viscosity and compatibility issues are avoided, but the cost increases and suitable larger packaging may not be available

Engineering Contradiction:
Improvevolume of drug substanceVSAvoidavailability of suitable packaging
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent applies parameter changes by modifying the fill volume parameter beyond the traditional nominal volume. Specifically, it fills the 1 mL syringe with 1.15 mL to 1.30 mL of drug substance, changing the volume parameter to achieve desired dosage volumes when larger packaging is unavailable. This resolves the contradiction by enabling use of smaller, more available packaging while delivering adequate drug quantities.

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If the nominal volume of the primary packaging component is increased to match the desired dosage volume, then the viscosity and compatibility issues are avoided, but the manufacturing cost increases

Engineering Contradiction:
Improvevolume of drug substanceVSAvoidmanufacturing cost
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent applies partial or excessive action by overfilling the syringe beyond its nominal volume. It fills a 1 mL syringe with 1.15 mL to 1.30 mL of drug substance, providing more than the nominal capacity. This excessive filling action allows use of smaller, less expensive packaging while ensuring sufficient drug substance volume for desired dosages, thereby reducing manufacturing costs associated with larger packaging.

Inventive Principle:
Principle #16Partial or excessive action

3Reliability

If vacuum is applied to the stopper during positioning, then the stopper is positioned correctly to maintain closure integrity, but the process complexity increases

Engineering Contradiction:
Improveclosure integrityVSAvoidstoppering process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies pneumatics by using vacuum pressure to position the stopper within the syringe. The vacuum force draws the stopper to the correct position, ensuring proper sealing and closure integrity. This pneumatic mechanism provides reliable stopper positioning while maintaining relatively simple process implementation, resolving the contradiction between reliability and complexity.

Inventive Principle:
Principle #29Pneumatics and hydraulics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Successfully fills primary packaging components with a desired volume of drug substance while maintaining closure integrity and sterility, avoiding issues related to viscosity and compatibility with delivery devices.

Implementation Method 1

positioning the stopper comprises applying a vacuum to the stopper

Methodology Applied
Scientific EffectVacuum: Vacuum

Data Source

PatentUS12440622B2Devices and methods for overfilling drug containers
Publication Date: 2025.10.14 REGENERON PHARMACEUTICALS INC
  • US12440622B2 patent drawing
  • US12440622B2 patent drawing
  • US12440622B2 patent drawing

AI summary

Disclosed herein are methods for overfilling primary packaging components, and drug products prepared according to those methods. The methods may include introducing a volume of a formulated drug substance into a primary packaging component having a nominal volume, where the volume of the formulated drug substance is greater than the nominal volume of the primary packaging component. In some cases, the primary packaging component may be a prefillable syringe.